Enanta Pharmaceuticals
ENTA
$13.23
Share price
-5.50%
Change (1 day)
-65.19%
Change (1 year)
Categories
Market capitalization of Enanta Pharmaceuticals (ENTA)
Market cap: $0.27 Billion
As of April 2024 Enanta Pharmaceuticals has a market cap of $0.27 Billion. This makes Enanta Pharmaceuticals the world's 6591th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Enanta Pharmaceuticals from 2013 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $0.27 B | 41.24% |
| 2023 | $0.19 B | -79.52% |
| 2022 | $0.96 B | -36.9% |
| 2021 | $1.53 B | 81.39% |
| 2020 | $0.84 B | -30.93% |
| 2019 | $1.22 B | -11.09% |
| 2018 | $1.37 B | 22.66% |
| 2017 | $1.12 B | 75.95% |
| 2016 | $0.63 B | 2.78% |
| 2015 | $0.62 B | -34.43% |
| 2014 | $0.94 B | 93.12% |
| 2013 | $0.49 B |
End of Day market cap according to different sources
On Apr 17th, 2024 the market cap of Enanta Pharmaceuticals was reported to be:
$0.29 Billion
$0.29 Billion
$0.29 Billion
$0.29 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $351.20 B | 125,376.62% | 🇺🇸 USA |
 Novartis NVS | $189.21 B | 67,502.72% | 🇨🇭 Switzerland |
 AbbVie ABBV | $291.55 B | 104,066.36% | 🇺🇸 USA |
 Vertex Pharmaceuticals VRTX | $101.69 B | 36,234.65% | 🇺🇸 USA |
 Merck MRK | $317.21 B | 113,232.73% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $97.89 B | 34,874.87% | 🇺🇸 USA |